JP7106646B2 - 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム - Google Patents

個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム Download PDF

Info

Publication number
JP7106646B2
JP7106646B2 JP2020535175A JP2020535175A JP7106646B2 JP 7106646 B2 JP7106646 B2 JP 7106646B2 JP 2020535175 A JP2020535175 A JP 2020535175A JP 2020535175 A JP2020535175 A JP 2020535175A JP 7106646 B2 JP7106646 B2 JP 7106646B2
Authority
JP
Japan
Prior art keywords
computer
model
neuron
physiological
ranges
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020535175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021509198A (ja
JP2021509198A5 (https=
Inventor
ルンベル、ティム
コズロスキ、ジェイムス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Business Machines Corp
Original Assignee
International Business Machines Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Business Machines Corp filed Critical International Business Machines Corp
Publication of JP2021509198A publication Critical patent/JP2021509198A/ja
Publication of JP2021509198A5 publication Critical patent/JP2021509198A5/ja
Application granted granted Critical
Publication of JP7106646B2 publication Critical patent/JP7106646B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/12—Computing arrangements based on biological models using genetic models
    • G06N3/126—Evolutionary algorithms, e.g. genetic algorithms or genetic programming

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Evolutionary Computation (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Artificial Intelligence (AREA)
  • Molecular Biology (AREA)
  • Software Systems (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computing Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Computational Linguistics (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2020535175A 2017-12-28 2018-12-06 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム Active JP7106646B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/856,582 2017-12-28
US15/856,582 US11227692B2 (en) 2017-12-28 2017-12-28 Neuron model simulation
PCT/IB2018/059697 WO2019130135A1 (en) 2017-12-28 2018-12-06 Neuron model generation for personalised drug treatment

Publications (3)

Publication Number Publication Date
JP2021509198A JP2021509198A (ja) 2021-03-18
JP2021509198A5 JP2021509198A5 (https=) 2021-04-30
JP7106646B2 true JP7106646B2 (ja) 2022-07-26

Family

ID=67058418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020535175A Active JP7106646B2 (ja) 2017-12-28 2018-12-06 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム

Country Status (5)

Country Link
US (1) US11227692B2 (https=)
JP (1) JP7106646B2 (https=)
CN (1) CN111465852B (https=)
DE (1) DE112018006656T5 (https=)
WO (1) WO2019130135A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021063937A1 (en) * 2019-09-30 2021-04-08 F. Hoffmann-La Roche Ag Means and methods for assessing huntington´s disease (hd)
CN112582069B (zh) * 2020-12-25 2023-01-17 南开大学 基于反应扩散模型的神经元树突棘发育模式建立方法
CN113161016A (zh) * 2020-12-31 2021-07-23 上海明品医学数据科技有限公司 一种智能医学服务系统、方法及存储介质
CN114358622B (zh) * 2022-01-07 2024-11-08 中创新航技术研究院(江苏)有限公司 工厂仿真方法及装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016517556A (ja) 2013-03-15 2016-06-16 ノースロップ グラマン システムズ コーポレイションＮｏｒｔｈｒｏｐ Ｇｒｕｍｍａｎ Ｓｙｓｔｅｍｓ Ｃｏｒｐｏｒａｔｉｏｎ 健康学習システム及び方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5121231A (en) * 1990-04-06 1992-06-09 University Of Southern California Incoherent/coherent multiplexed holographic recording for photonic interconnections and holographic optical elements
US5849995A (en) 1993-09-27 1998-12-15 The University Of British Columbia Mouse model for Huntington's Disease and related DNA sequences
AUPP398898A0 (en) 1998-06-09 1998-07-02 University Of Queensland, The Diagnostic method and apparatus
DE19832053A1 (de) * 1998-07-16 2000-01-27 Siemens Ag Verfahren zur Ermittlung des im Rahmen des Parkinson-Syndroms bzw. der Parkinson-Krankheit relevanten klinischen Zustands eines Patienten, sowie System hierfür
US6933147B2 (en) * 2000-08-17 2005-08-23 Icagen, Inc. Human cyclic nucleotide-gated channel polypeptide
US7461006B2 (en) 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
US20040241720A1 (en) * 2003-02-26 2004-12-02 Salkoff Lawrence B. Sodium activated potassium ion channel for therapeutic drug screening
US20080038730A1 (en) * 2004-05-10 2008-02-14 Heinz Von Der Kammer Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease
JP5307397B2 (ja) * 2004-09-18 2013-10-02 ユニバーシティ オブ メリーランド，ボルチモア ＮＣＣａ−ＡＴＰチャネルを標的とする治療剤およびその使用方法
CA2590377A1 (en) * 2004-12-16 2006-06-22 Novascreen Biosciences A method for identification and functional characterization of agents which modulate ion channel activity
KR20070111475A (ko) * 2005-01-04 2007-11-21 노파르티스 아게 만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
CA2628108C (en) 2005-11-10 2020-01-07 Certara Usa, Inc. Method and apparatus for computer modeling the human brain for predicting drug effects
US7945392B2 (en) 2005-11-14 2011-05-17 Mclean Hospital Corporation Methods and systems for drug screening and computational modeling based on biologically realistic neurons
EP3703058A1 (en) 2005-11-29 2020-09-02 Children's Hospital Medical Center A method of selecting a medication for a patient
US20090306534A1 (en) * 2006-04-03 2009-12-10 President And Fellows Of Harvard College Systems and methods for predicting effectiveness in the treatment of psychiatric disorders, including depression
CN103424541B (zh) * 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
JP5670755B2 (ja) * 2008-03-12 2015-02-18 ザ ロックフェラー ユニバーシティ 翻訳プロファイリング及び分子表現型解析のための方法及び組成物
CA2725138A1 (en) * 2008-05-21 2009-11-26 Kinemed, Inc. Compositions and methods of treatment using modulators of motoneuron diseases
WO2009152485A2 (en) * 2008-06-13 2009-12-17 Ipierian, Inc. Methods of cell-based technologies
CN101658522B (zh) * 2008-08-26 2013-01-02 香港理工大学深圳研究院 他克林短链二聚体类化合物在制备治疗神经退行性疾病药物中的应用
JP2012521767A (ja) * 2009-03-26 2012-09-20 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 薬剤代謝に影響を及ぼすｃｙｐ３ａ４遺伝子における多型およびその使用
EP2603900B1 (en) * 2010-08-13 2024-04-24 Intellimedicine, Inc. System and methods for the production of personalized drug products
BR112014003811A2 (pt) * 2011-08-26 2017-03-14 Hoffmann La Roche método para predizer benefício clínico no tratamento de transtornos de neurodesenvolvimento, neurológicos ou neuropsiquiátricos
US20130262155A1 (en) 2012-04-03 2013-10-03 Thomas J. HinKamp System and method for collection and distibution of medical information
JP2014239871A (ja) * 2013-05-07 2014-12-25 安東　秀夫 生体活動検出方法、生体活動測定装置、生体活動検出信号の転送方法および生体活動情報を利用したサービスの提供方法
US20140358512A1 (en) * 2013-06-03 2014-12-04 International Business Machines Corporation Automated construction of ion-channel models in a multi-comparment models
CN111710434B (zh) * 2013-08-19 2021-10-26 塞弗欧米公司 用于确定对蛋白质的功能的影响的方法和系统
WO2015085432A1 (en) * 2013-12-13 2015-06-18 The Governors Of The University Of Alberta Systems and methods of selecting compounds with reduced risk of cardiotoxicity
US20150301030A1 (en) * 2014-04-22 2015-10-22 Q-State Biosciences, Inc. Models for parkinson's disease studies
EP3006055B1 (en) * 2014-10-10 2020-02-19 Albert-Ludwigs-Universität Freiburg Improved biomaterials for neuronal implants and use of said biomaterials in the diagnosis and therapy of neuronal diseases
KR101617683B1 (ko) * 2015-01-09 2016-05-03 연세대학교 산학협력단 부정맥 치료제 효과 평가 시스템 및 방법
US11179192B2 (en) * 2015-07-29 2021-11-23 Atricure, Inc. Ablation devices and methods of use
EP3410926A4 (en) * 2016-02-01 2019-08-28 The Board of Trustees of the Leland Stanford Junior University METHOD AND SYSTEMS FOR ANALYZING FUNCTIONAL IMAGING DATA
CN105998316B (zh) * 2016-05-23 2019-12-03 齐齐哈尔医学院 一种治疗老年性痴呆的中药组合物及其具体制备方法和相关应用
CN120636518A (zh) * 2017-05-12 2025-09-12 密歇根大学董事会 个体和队列药理学表型预测平台
EP3723844B1 (en) * 2017-12-12 2023-08-09 Duke University Systems and methods for minimizing response variability of spinal cord stimulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016517556A (ja) 2013-03-15 2016-06-16 ノースロップ グラマン システムズ コーポレイションＮｏｒｔｈｒｏｐ Ｇｒｕｍｍａｎ Ｓｙｓｔｅｍｓ Ｃｏｒｐｏｒａｔｉｏｎ 健康学習システム及び方法

Also Published As

Publication number Publication date
CN111465852B (zh) 2022-08-19
JP2021509198A (ja) 2021-03-18
US20190206573A1 (en) 2019-07-04
DE112018006656T5 (de) 2020-10-08
US11227692B2 (en) 2022-01-18
CN111465852A (zh) 2020-07-28
WO2019130135A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
Van Der Wijst et al. An integrative approach for building personalized gene regulatory networks for precision medicine
JP7106646B2 (ja) 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム
Zickenrott et al. Prediction of disease–gene–drug relationships following a differential network analysis
Gjuvsland et al. Bridging the genotype–phenotype gap: what does it take?
Druckmann et al. A novel multiple objective optimization framework for constraining conductance-based neuron models by experimental data
Noebels Pathway-driven discovery of epilepsy genes
Cannon et al. Stochastic ion channel gating in dendritic neurons: morphology dependence and probabilistic synaptic activation of dendritic spikes
Seo et al. Dynamic signals related to choices and outcomes in the dorsolateral prefrontal cortex
Dixit et al. Inferring transition rates of networks from populations in continuous-time Markov processes
Negrello et al. Quasiperiodic rhythms of the inferior olive
Williams et al. Dendritic trafficking faces physiologically critical speed-precision tradeoffs
KR20160042825A (ko) 패러다임 약물 반응 네트워크
Singh et al. Presynaptic endoplasmic reticulum regulates short-term plasticity in hippocampal synapses
Pena-Chilet et al. Using mechanistic models for the clinical interpretation of complex genomic variation
US20170316148A1 (en) Method To Identify Genes Under Positive Selection
Gorur-Shandilya et al. Activity-dependent compensation of cell size is vulnerable to targeted deletion of ion channels
Schneider et al. Biological complexity facilitates tuning of the neuronal parameter space
Mäki-Marttunen et al. Functional effects of schizophrenia-linked genetic variants on intrinsic single-neuron excitability: a modeling study
Siekmann et al. Data-Driven Modelling of the Inositol Trisphosphate Receptor () and its Role in Calcium-Induced Calcium Release (CICR)
Ma et al. Considerations for integrative multi‐omic approaches to explore Alzheimer's disease mechanisms
Mäki-Marttunen et al. Pleiotropic effects of schizophrenia-associated genetic variants in neuron firing and cardiac pacemaking revealed by computational modeling
Esteban-Medina et al. The mechanistic functional landscape of retinitis pigmentosa: A machine learning-driven approach to therapeutic target discovery
Francisco et al. Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50
US20050130192A1 (en) Apparatus and method for identifying therapeutic targets using a computer model
Xu et al. Structural Insights into the Substrate Egress Pathways Explains Specificity and Inhibition of Human Glucose Transporters (GLUT1 and GLUT9)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210525

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20220502

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220627

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220705

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220713

R150 Certificate of patent or registration of utility model

Ref document number: 7106646

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150